The Gilead pact signed between Jubilant Life Sciences' subsidiary Jubilant Generics Ltd and Gilead, will grant the former the right to register, manufacture and sell the latter's investigation drug, remdesivir - a potential therapy for Covid-19. from Top Business News- News18.com Read The Rest:timesnownews...
No comments: